A new meta-analysis of 55 studies involving more than 3 million people has found that 31% of individuals with cannabis use ...
Researchers discover a paradox: high cognitive performance predicts depressive relapse, contradicting traditional expectations.
A meta-analysis of studies involving over 3.2 million participants found that major depressive disorder is significantly more ...
What social risk factors affecting your patients may affect their risk of major depressive disorder more than they realize?
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...
Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...
Experiences of cognitive problems such as memory loss or difficulty concentrating, known as "brain fog," may not predict ...
The study found that the active ingredient in GLP-1 drugs "significantly improved" motivation in patients with major ...
Before your first psychiatrist appointment for major depressive disorder, you can do many things to prepare. By planning ahead, you’re doing everything on your end to make sure you have a smooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results